Published • loading... • Updated
Cutting-edge drug shows promise for patients with NRAS-driven melanoma
Summary by Medical Xpress
1 Articles
1 Articles
Cutting-edge drug shows promise for patients with NRAS-driven melanoma
A research team from Huntsman Cancer Institute at the University of Utah (the U) reports that a pathway-targeted therapy could be an effective treatment for certain melanoma patients and fill an unmet clinical need for patients with advanced disease.
·Douglas, United Kingdom
Read Full ArticleCoverage Details
Total News Sources1
Leaning Left0Leaning Right0Center1Last UpdatedBias Distribution100% Center
Bias Distribution
- 100% of the sources are Center
100% Center
C 100%
Factuality
To view factuality data please Upgrade to Premium
